AAAAAA
Results: 1-25/49
Authors:
Mercadante, S
Villari, P
Fulfaro, F
Citation: S. Mercadante et al., Rifampicin in opioid-induced itching, SUPP CARE C, 9(6), 2001, pp. 467-468
Authors:
Mercadante, S
Fulfaro, F
Casuccio, A
Citation: S. Mercadante et al., The use of corticosteroids in home palliative care, SUPP CARE C, 9(5), 2001, pp. 386-389
Authors:
Ripamonti, C
Twycross, R
Baines, M
Bozzetti, F
Capri, S
De Conno, F
Gemlo, B
Hunt, TM
Krebs, HB
Mercadante, S
Schaerer, R
Wilkinson, P
Citation: C. Ripamonti et al., Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer, SUPP CARE C, 9(4), 2001, pp. 223-233
Authors:
Mercadante, S
Villari, P
Fulfaro, F
Citation: S. Mercadante et al., Gabapentin for opioid-related myoclonus in cancer patients, SUPP CARE C, 9(3), 2001, pp. 205-206
Authors:
Mercadante, S
Fulfaro, F
Dabbene, M
Citation: S. Mercadante et al., Methadone in treatment of tenesmus not responding to morphine escalation, SUPP CARE C, 9(2), 2001, pp. 129-130
Authors:
Mercadante, S
Villari, P
Ferrera, P
Dabbene, M
Citation: S. Mercadante et al., Pamidronate in incident pain due to bone metastases, J PAIN SYMP, 22(2), 2001, pp. 630-631
Authors:
Mercadante, S
Villari, P
Ferrera, P
Citation: S. Mercadante et al., Clinical problems with transdermal fentanyl titration from 25 to 50 mu g/hr, J PAIN SYMP, 21(6), 2001, pp. 448-449
Authors:
Mercadante, S
Citation: S. Mercadante, Setting up a "pain-free" hospital, J PAIN SYMP, 21(5), 2001, pp. 364-365
Authors:
Mercadante, S
Serretta, R
Casuccio, A
Citation: S. Mercadante et al., Effects of caffeine as an adjuvant to morphine in advanced cancer patients: A randomized, double-blind, placebo-controlled, crossover study, J PAIN SYMP, 21(5), 2001, pp. 369-372
Authors:
Mercadante, S
Portenoy, RK
Citation: S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 3. Clinical strategies lo improve opioid responsiveness, J PAIN SYMP, 21(4), 2001, pp. 338-354
Authors:
Mercadante, S
Portenoy, RK
Citation: S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 2: Basic mechanisms that could shift dose response for analgesia, J PAIN SYMP, 21(3), 2001, pp. 255-264
Authors:
Mercadante, S
Portenoy, RK
Citation: S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 1: Clinical considerations, J PAIN SYMP, 21(2), 2001, pp. 144-150
Authors:
Grassi, L
Caraceni, A
Beltrami, E
Borreani, C
Zamorani, M
Maltoni, M
Monti, M
Luzzani, M
Mercadante, S
De Conno, F
Citation: L. Grassi et al., Assessing delirium in cancer patients. The Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale, J PAIN SYMP, 21(1), 2001, pp. 59-68
Authors:
Mercadante, S
Fulfaro, F
Casuccio, A
Citation: S. Mercadante et al., Pattern of drug use by advanced cancer patients followed at home, J PALLIAT C, 17(1), 2001, pp. 37-40
Authors:
Cherny, N
Ripamonti, C
Pereira, J
Davis, C
Fallon, M
McQuay, H
Mercadante, S
Pasternak, G
Ventafridda, V
Citation: N. Cherny et al., Strategies to manage the adverse effects of oral morphine: An evidence-based report, J CL ONCOL, 19(9), 2001, pp. 2542-2554
Authors:
Mercadante, S
Casuccio, A
Fulfaro, F
Groff, L
Boffi, R
Villari, P
Gebbia, V
Ripamonti, C
Citation: S. Mercadante et al., Switching from morphine to methadone to improve analgesia and tolerabilityin cancer patients: A prospective study, J CL ONCOL, 19(11), 2001, pp. 2898-2904
Authors:
Mercadante, S
Citation: S. Mercadante, The use of anti-inflammatory drugs in cancer pain, CANC TR REV, 27(1), 2001, pp. 51-61
Authors:
Hanks, GW
de Conno, F
Cherny, N
Hanna, M
Kalso, E
McQuay, HJ
Mercadante, S
Meynadier, J
Poulain, P
Ripamonti, C
Radbruch, L
Casas, JRI
Sawe, J
Twycross, RG
Ventafridda, V
Citation: Gw. Hanks et al., Morphine and alternative opioids in cancer pain: the EAPC recommendations, BR J CANC, 84(5), 2001, pp. 587-593
Authors:
Mercadante, S
Citation: S. Mercadante, Timing for narcotic drugs in terminal illness, TOP AN CRIT, 2001, pp. 105-110
Authors:
Mercadante, S
Fulfaro, F
Casuccio, A
Citation: S. Mercadante et al., The impact of home palliative care on symptoms in advanced cancer patients, SUPP CARE C, 8(4), 2000, pp. 307-310
Authors:
Mercadante, S
Ripamonti, C
Casuccio, A
Zecca, E
Groff, L
Citation: S. Mercadante et al., Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction, SUPP CARE C, 8(3), 2000, pp. 188-191
Authors:
Mercadante, S
Casuccio, A
Pumo, S
Fulfaro, F
Citation: S. Mercadante et al., Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender, SUPP CARE C, 8(2), 2000, pp. 123-130
Authors:
Arcuri, E
Mercadante, S
Laurenzi, L
Natoli, S
Centulio, F
Fusco, G
Ginobbi, P
Tirelli, T
Citation: E. Arcuri et al., Opioid nonresponsiveness in cancer pain can be reversible. A serendipitousconclusion of a retrospective analysis, J PAIN SYMP, 20(6), 2000, pp. 393-394
Authors:
Mercadante, S
Arcuri, E
Tirelli, W
Casuccio, A
Citation: S. Mercadante et al., Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, controlled, double-blind, crossover, double-dose study, J PAIN SYMP, 20(4), 2000, pp. 246-252
Authors:
Mercadante, S
Casuccio, A
Fulfaro, F
Citation: S. Mercadante et al., The course of symptom frequency and intensity in advanced cancer patients followed at home, J PAIN SYMP, 20(2), 2000, pp. 104-112